Marsh, P.
Radif, D.
Rajpurkar, P.
Wang, Z.
Hariton, E.
Ribeiro, S.
Simbulan, R.
Kaing, A.
Lin, W.
Rajah, A.
Rabara, F.
Lungren, M.
Demirci, U.
Ng, A.
Rosen, M.
Article History
Received: 24 August 2022
Accepted: 24 November 2022
First Online: 7 December 2022
Competing interests
: Eduardo Hariton reports that he is a paid consultant of Alife Health. Utkan Demirci reports that he is a founder of and has an equity interest in: DxNow Inc., Koek Biotech, Levitas Inc., Hillel Inc., and Mercury Biosciences. The remaining authors declare no competing interests.